Overview
IQV market data
Price History
IQV price chart · 1M
- O
- 273.76
- H
- 273.76
- L
- 269.62
- C
- 270.26
- Vol
- 72,445.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $273.76
- Previous Close
- $275.04
- Day High
- $273.76
- Day Low
- $269.62
- 52 Week High
- $277.03
- 52 Week Low
- $162.44
- 7 Day Return
- +1.39%
- 30 Day Return
- +3.32%
- 90 Day Return
- +39.77%
- 1 Year Return
- +44.69%
- Daily Notional Volume
- $19.6M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 32.95 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $7.84 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.18 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 8.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $154.50 – $277.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $45.3B · P/B 5.90 · P/S 2.67.
Company News
10 captured
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global RegionsGlobenewswire Inc ·
Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the RegionGlobenewswire Inc ·
8-K filing — IQVIA HOLDINGS INC. (IQV)SEC EDGAR ·
Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share OutlookGlobenewswire Inc ·
IQVIA Stock Rises 60% in 6 Months: Here's What You Should KnowZacks Investment Research ·
VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate FastZacks Investment Research ·